4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-25-000375
CIK 0001878313other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:05 PM ET
Size
5.2 KB
Accession
0001127602-25-000375
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2024-12-31+10,225→ 10,225 totalExercise: $1.98From: 2024-12-31Exp: 2034-12-31→ Common Stock (10,225 underlying)
Footnotes (1)
- [F1]The stock options, granted on December 31, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:05 PM ET
- Size
- 5.2 KB